161 related articles for article (PubMed ID: 7050931)
1. Special feature: in quest of an effective antiemetic in cancer chemotherapy. Research with antiemetics for cancer chemotherapy: problems and possibilities.
Maxwell MB
Oncol Nurs Forum; 1982; 9(3):11-6. PubMed ID: 7050931
[No Abstract] [Full Text] [Related]
2. Problems in antiemetic trial design and interpretation.
Krasnow SH
Oncology (Williston Park); 1989 Aug; 3(8 Suppl):5-10. PubMed ID: 2701576
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic studies: a methodological discussion.
Olver IN; Simon RM; Aisner J
Cancer Treat Rep; 1986 May; 70(5):555-63. PubMed ID: 3708607
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic study design: a discussion of Dr Olver's paper.
Groshen S
Br J Cancer Suppl; 1992 Dec; 19():S35-7. PubMed ID: 1467199
[No Abstract] [Full Text] [Related]
5. [Comparative trial between two drugs in the treatment of vomiting induced by anti-cancer chemotherapy (author's transl)].
Zylberait D; Krulik M; Audebert AA; Debray J
Sem Hop; 1981 Jan 8-15; 57(1-2):47-9. PubMed ID: 6258237
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of antiemetic properties of clebopride and metoclopramide in vomiting produced by cis-platinum (author's transl)].
Padrón F; Sanz J; Flórez J
Med Clin (Barc); 1981 Sep; 77(4):167-70. PubMed ID: 7031384
[No Abstract] [Full Text] [Related]
7. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
Herrstedt J
Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
[TBL] [Abstract][Full Text] [Related]
8. Antiemetic therapy in patients treated with cisplatin chemotherapy.
Roila F; Basurto C; Bracarda S; Del Favero A; Tonato M
J Chemother; 1989 Jul; 1(4 Suppl):1281-5. PubMed ID: 16312866
[No Abstract] [Full Text] [Related]
9. Antiemetic study design: desirable objectives, stratifications and analyses.
Olver IN
Br J Cancer Suppl; 1992 Dec; 19():S30-3; discussion S33-4. PubMed ID: 1467198
[TBL] [Abstract][Full Text] [Related]
10. Measurement of success: parameters of efficacy.
de Mulder PH
Br J Cancer Suppl; 1992 Dec; 19():S68. PubMed ID: 1467205
[No Abstract] [Full Text] [Related]
11. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
[No Abstract] [Full Text] [Related]
12. [Significance and principles of antiemetic therapy in cytostatic treatment].
Joss R; Buser K; Cerny T; Rohrbach D; Brunner KW
Ther Umsch; 1988 Jun; 45(6):397-402. PubMed ID: 3046037
[No Abstract] [Full Text] [Related]
13. The use of dexamethasone (Hexadrol) as an antiemetic in association with chemotherapy for neoplastic disease.
Gathercole F; Connolly N; Birdsell J
Oncol Nurs Forum; 1982; 9(3):17-9. PubMed ID: 6921787
[No Abstract] [Full Text] [Related]
14. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
Bilgrami S; Fallon BG
Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
[TBL] [Abstract][Full Text] [Related]
15. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
Hesketh PJ
Oncologist; 1999; 4(3):191-6. PubMed ID: 10394587
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
17. Carryover and the two-period crossover clinical trial.
Willan AR; Pater JL
Biometrics; 1986 Sep; 42(3):593-9. PubMed ID: 3567292
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
Jordan K; Sippel C; Schmoll HJ
Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
[TBL] [Abstract][Full Text] [Related]
19. Nurses' perceptions of antiemetic effectiveness.
Rhodes VA; McDaniel RW; Simms SG; Johnson M
Oncol Nurs Forum; 1995 Sep; 22(8):1243-52. PubMed ID: 8532549
[TBL] [Abstract][Full Text] [Related]
20. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
